Search

Arvinder S Sran

age ~51

from Fremont, CA

Get Report
Also known as:
  • Arvinder Singh Sran
  • Aruinder S Sran
  • As Sran
  • Sran S Arvinder
  • Sran As
Phone and address:
37623 Central Cove Ct, Fremont, CA 94536
Related to:
Connected to:

Arvinder Sran Phones & Addresses

  • 37623 Central Cove Ct, Fremont, CA 94536
  • 39900 Blacow Rd, Fremont, CA 94538
  • San Pablo, CA
  • Sunnyvale, CA
  • San Leandro, CA
  • Union City, CA
  • Alameda, CA

Resumes

Arvinder Sran Photo 1

Scientist Ii

view source
Location:
37623 Central Cove Ct, Fremont, CA 94536
Industry:
Biotechnology
Work:
Ardelyx, Inc.
Scientist Ii
Myokardia Dec 2012 - Jun 2015
Associate Scientist
Portola Pharmaceuticals Dec 2012 - Jun 2015
Scientist
Portola Pharmaceuticals Jul 2009 - Nov 2012
Associate Scientist
Rigel Pharmaceuticals Inc. Feb 2003 - Feb 2009
Process Development Chemist
Education:
Guru Nanak Dev University 1996
Masters, Chemistry Guru Nanak Dev University 1994
Bachelors, Chemistry
Skills:
Immunology
Lifesciences
Biotechnology
Inflammation
Medicinal Chemistry
Drug Development
Drug Discovery
Glp
Hplc
Lc Ms
Clinical Development
Organic Chemistry
Arvinder Sran Photo 2

Associate Scientist At Myokardia Inc.

view source
Position:
Associate Scientist at MyoKardia Inc.
Location:
San Francisco Bay Area
Industry:
Biotechnology
Work:
MyoKardia Inc. since Dec 2012
Associate Scientist
Portola Pharmaceuticals Jul 2009 - Nov 2012
Associate Scientist
Skills:
Immunology
Lifesciences
Biotechnology
Inflammation
Medicinal Chemistry
Drug Development
Drug Discovery
GLP
HPLC
LC-MS

Us Patents

  • Compositions And Methods For Inhibition Of The Jak Pathway

    view source
  • US Patent:
    8193197, Jun 5, 2012
  • Filed:
    Oct 19, 2007
  • Appl. No.:
    11/875772
  • Inventors:
    Hui Li - Santa Clara CA, US
    Ankush Argade - Foster City CA, US
    Sambaiah Thota - Fremont CA, US
    David Carroll - San Francisco CA, US
    Arvinder Sran - Fremont CA, US
    Robin Cooper - St. George Island FL, US
    Rajinder Singh - Belmont CA, US
    Kin Tso - San Francisco CA, US
    Somasekhar Bhamidipati - Foster City CA, US
  • Assignee:
    Rigel Pharmaceuticals, Inc. - South San Francisco CA
  • International Classification:
    A01N 43/54
    C07D 239/42
  • US Classification:
    514256, 544242
  • Abstract:
    The invention encompasses compounds having formula I and the compositions and methods using these compounds in the treatment of conditions in which modulation of the JAK pathway or inhibition of JAK kinases are therapeutically useful.

  • Compositions And Methods For Inhibition Of The Jak Pathway

    view source
  • US Patent:
    8299087, Oct 30, 2012
  • Filed:
    Oct 11, 2010
  • Appl. No.:
    12/902052
  • Inventors:
    Hui Li - Santa Clara CA, US
    Vanessa Taylor - San Francisco CA, US
    Somasekhar Bhamidipati - Foster City CA, US
    John Ramphal - Union City CA, US
    Kin Tso - San Francisco CA, US
    Arvinder Sran - Fremont CA, US
    Holger Keim - Irvine CA, US
    Vadim Markovtsov - San Mateo CA, US
    David Carroll - San Francisco CA, US
    Sambaiah Thota - Fremont CA, US
    Ankush Argade - Foster City CA, US
    Jeffrey Wayne Clough - Redwood City CA, US
    Rajinder Singh - Belmont CA, US
    Robin Cooper - St. George Island FL, US
  • Assignee:
    Rigel Pharmaceuticals, Inc. - South San Francisco CA
  • International Classification:
    A61K 31/505
  • US Classification:
    514275
  • Abstract:
    The invention encompasses compounds having formula I and the compositions and methods using these compounds in the treatment of conditions in which modulation of the JAK pathway or inhibition of JAK kinases, particularly JAK3, are therapeutically useful.

  • Compositions And Methods For Inhibition Of The Jak Pathway

    view source
  • US Patent:
    8399472, Mar 19, 2013
  • Filed:
    Aug 18, 2008
  • Appl. No.:
    12/193627
  • Inventors:
    Hui Li - Santa Clara CA, US
    Sambaiah Thota - Fremont CA, US
    David Carroll - San Francisco CA, US
    Ankush Argade - Foster City CA, US
    Kin Tso - San Francisco CA, US
    Arvinder Sran - Fremont CA, US
    Jeffrey Clough - Redwood City CA, US
    Holger Keim - Wyckoff NJ, US
    Somasekhar Bhamidipati - Foster City CA, US
    Vanessa Taylor - San Francisco CA, US
    Robin Cooper - St. George Island FL, US
    Rajinder Singh - Belmont CA, US
    Brian Wong - Los Altos CA, US
  • Assignee:
    Rigel Pharmaceuticals, Inc. - South San Francisco CA
  • International Classification:
    C07D 239/48
    A61K 31/506
  • US Classification:
    514275, 544323, 544324
  • Abstract:
    The invention encompasses compounds having formula I-V and the compositions and methods using these compounds in the treatment of conditions in which modulation of the JAK pathway or inhibition of JAK kinases, particularly JAK3, may be therapeutically useful.

  • Compositions And Methods For Inhibition Of The Jak Pathway

    view source
  • US Patent:
    8415365, Apr 9, 2013
  • Filed:
    Feb 12, 2008
  • Appl. No.:
    12/030031
  • Inventors:
    Hui Li - Santa Clara CA, US
    Sambaiah Thota - Fremont CA, US
    David Carroll - San Francisco CA, US
    Ankush Argade - Foster City CA, US
    Kin Tso - San Francisco CA, US
    Arvinder Sran - Fremont CA, US
    Jeffrey Clough - Redwood City CA, US
    Holger Keim - Wyckoff NJ, US
    Somasekhar Bhamidipati - Foster City CA, US
    Vanessa Taylor - San Francisco CA, US
    Robin Cooper - St. George Island FL, US
    Rajinder Singh - Belmont CA, US
    Brian Wong - Los Altos CA, US
  • Assignee:
    Rigel Pharmaceuticals, Inc. - South San Francisco CA
  • International Classification:
    C07D 239/48
    A61K 31/505
  • US Classification:
    514275, 544323, 544324
  • Abstract:
    The invention encompasses compounds having formula I-V and the compositions and methods using these compounds in the treatment of conditions in which modulation of the JAK pathway or inhibition of JAK kinases, particularly JAK3, may be therapeutically useful.

  • Compositions And Methods For Inhibition Of The Jak Pathway

    view source
  • US Patent:
    20060293311, Dec 28, 2006
  • Filed:
    Jun 8, 2006
  • Appl. No.:
    11/450901
  • Inventors:
    Hui Li - Santa Clara CA, US
    Sambaiah Thota - Fremont CA, US
    David Carroll - San Francisco CA, US
    Ankush Argade - Foster City CA, US
    Kin Tso - San Francisco CA, US
    Arvinder Sran - Fremont CA, US
    Jeffrey Clough - Redwood City CA, US
    Holger Keim - Wyckoff NJ, US
    Somasekhar Bhamidipati - Foster City CA, US
    Vanessa Taylor - San Francisco CA, US
    Robin Cooper - St. George Island FL, US
    Rajinder Singh - Belmont CA, US
    Brian Wong - Los Altos CA, US
  • International Classification:
    A61K 31/549
    A61K 31/506
    A61K 31/505
    C07D 417/02
    C07D 403/02
  • US Classification:
    514223200, 544013000, 544323000, 544324000, 514275000
  • Abstract:
    The invention encompasses compounds having formula I-V and the compositions and methods using these compounds in the treatment of conditions in which modulation of the JAK pathway or inhibition of JAK kinases, particularly JAK3, may be therapeutically useful.

  • Compositions And Methods For Inhibition Of The Jak Pathway

    view source
  • US Patent:
    20070203161, Aug 30, 2007
  • Filed:
    Feb 23, 2007
  • Appl. No.:
    11/678429
  • Inventors:
    Ankush ARGADE - Foster City CA, US
    Arvinder Sran - Fremont CA, US
    David Carroll - San Francisco CA, US
    Jeffrey Clough - Redwood City CA, US
    Kin Tso - San Francisco CA, US
    Somasekhar Bhamidipati - Foster City CA, US
    Sambaiah Thota - Fremont CA, US
    Rajinder Singh - Belmont CA, US
    Vanessa Taylor - San Francisco CA, US
    Hui Li - Santa Clara CA, US
    Esteban Masuda - Menlo Park CA, US
  • International Classification:
    A61K 31/505
  • US Classification:
    514275, 544297
  • Abstract:
    The invention encompasses compounds having formula I and the compositions and methods using these compounds in the treatment of conditions in which modulation of the JAK pathway or inhibition of JAK kinases, particularly JAK3, are therapeutically useful.

  • Compositions And Methods For Inhibition Of The Jak Pathway

    view source
  • US Patent:
    20070203162, Aug 30, 2007
  • Filed:
    Feb 23, 2007
  • Appl. No.:
    11/678488
  • Inventors:
    Hui Li - Santa Clara CA, US
    Ankush Argade - Foster City CA, US
    Kin Tso - San Francisco CA, US
    Sambaiah Thota - Fremont CA, US
    David Carroll - San Francisco CA, US
    Arvinder Sran - Fremont CA, US
    Robin Cooper - St. George Island FL, US
    Rajinder Singh - Belmont CA, US
    Somasekhar Bhamidipati - Foster City CA, US
    Vanessa Taylor - San Francisco CA, US
    Esteban Masuda - Menlo Park CA, US
  • International Classification:
    A61K 31/506
    C07D 403/02
  • US Classification:
    514275000, 544329000
  • Abstract:
    The invention encompasses compounds having formula I and the compositions and methods using these compounds in the treatment of conditions in which modulation of the JAK pathway or inhibition of JAK kinases, particularly JAK3, are therapeutically useful.

  • Compositions And Methods For Inhibition Of The Jak Pathway

    view source
  • US Patent:
    20080221089, Sep 11, 2008
  • Filed:
    Feb 12, 2008
  • Appl. No.:
    12/030069
  • Inventors:
    Ankush Argade - Foster City CA, US
    Arvinder Sran - Fremont CA, US
    David Carroll - San Francisco CA, US
    Jeffrey Clough - Redwood City CA, US
    Kin Tso - San Francisco CA, US
    Somasekhar Bhamidipati - Foster City CA, US
    Sambaiah Thota - Fremont CA, US
    Rajinder Singh - Belmont CA, US
    Vanessa Taylor - San Francisco CA, US
    Hui Li - Santa Clara CA, US
    Esteban Masuda - Menlo Park CA, US
  • International Classification:
    A61K 31/5415
    C07D 239/48
    A61K 31/505
    A61P 43/00
    C12N 9/99
    C07D 279/16
  • US Classification:
    5142278, 544323, 514275, 544 50, 435184
  • Abstract:
    The invention encompasses compounds having formula I and the compositions and methods using these compounds in the treatment of conditions in which modulation of the JAK pathway or inhibition of JAK kinases, particularly JAK3, are therapeutically useful.

Googleplus

Arvinder Sran Photo 3

Arvinder Sran

Get Report for Arvinder S Sran from Fremont, CA, age ~51
Control profile